Thoughts on prior authorization, healthcare technology, and building a better system.
New research shows that heart failure patients waiting on prior authorization take 3x longer to fill ARNIs and 6x longer for SGLT2 inhibitors — guideline-recommended therapies that reduce mortality.
New transparency data shows that 4 out of 5 prior auth denials are reversed when appealed. The initial denial isn't a medical decision — it's a bet that you won't fight back.
A Johns Hopkins study found that every oncologist surveyed reported patient harm from prior authorization. 80% watched cancer progress while waiting. 36% lost a patient.
Prior authorization was designed to control costs. Instead, it's become the single biggest administrative burden in healthcare. Here's why, and how Artificer Health is fixing it.